Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 09, 2016 1:30 AM ET

Health Care Technology

Company Overview of IMS Health Holdings, Inc.

Company Overview

IMS Health Holdings, Inc. provides information and technology services to healthcare industry worldwide. Its principal products include national information offerings that provide performance metrics related to the sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity through multiple channels; and sub-national offerings, which offer information related to the measurement of sales at the regional, zip code, and individual prescriber level. The company also provides workflow analytics, a set of strategic, analytic, and support services for life sciences companies; and real-world evidence solutions, which integrate information from medical claims, pr...

83 Wooster Heights Road

Danbury, CT 06810

United States

Founded in 1954

15,000 Employees

Phone:

203-448-4600

Key Executives for IMS Health Holdings, Inc.

Chairman, Chief Executive Officer and President
Age: 54
Total Annual Compensation: $1.6M
Chief Financial Officer and Senior Vice President
Age: 54
Total Annual Compensation: $457.5K
Senior Vice President of Global Services
Age: 50
Total Annual Compensation: $426.3K
Compensation as of Fiscal Year 2014.

IMS Health Holdings, Inc. Key Developments

IMS Health Holdings, Inc. Announces Unaudited Consolidated Financial Results for the Fourth Quarter and Full Year Ended December 31, 2015; Provides Financial Guidance for the Full Year of 2016

IMS Health Holdings, Inc. announced unaudited consolidated financial results for the fourth quarter and full year ended December 31, 2015. Revenue for the fourth quarter of $812 million was up 28.3% on a constant currency basis and 19.7% on a reported basis compared with $678 million for the fourth quarter of 2014. Excluding the impact of the acquisition of Cegedim’s CRM and Strategic Data businesses, revenue was up 6.8% on a constant currency basis and up 0.7% on a reported basis, with the difference entirely due to the year-over-year strengthening of the U.S. dollar versus currencies in which the company transacts business. Operating income was $88 million against $87 million for the same period of last year. Income before income taxes was $48 million against $53 million for the same period of last year. Net income was $29 million against $8 million for the same period of last year. Earnings per diluted share attributable the company to was $0.09 against $0.03 for the same period of last year. Adjusted net income was $125 million against $125 million for the same period of last year. Adjusted diluted earnings per share was $0.37 against $0.36 for the same period of last year. Net cash provided by operating activities was $164 million against $147 million for the same period of last year. Capital expenditures were $23 million against $13 million for the same period of last year. Additions to computer software were $44 million against $25 million for the same period of last year. Free cash flow was $97 million against $109 million for the same period of last year. Unlevered free cash flow was $211 million against $182 million for the same period of last year. Adjusted EBITDA was $232 million improved 16.8% at constant currency and 8.4% reported compared with $214 million for the fourth quarter of 2014. Revenue for the year ended December 31, 2015 of $2,921 million increased 21% on a constant currency basis and 10.6% reported compared with $2,641 million for the year 2014. Excluding the impact of the Cegedim Acquisition, revenue was up 5.8% on a constant currency basis and down 2.6% on a reported basis. Adjusted EBITDA of $886 million increased 11.2% at constant currency and 0.9% reported compared with $878 million for the year 2014. Operating income was $364 million against $208 million for the same period of last year. Income before income taxes was $217 million against loss of $285 million for the same period of last year. Net income was $417 million against loss of $189 million for the same period of last year. Earnings per diluted share attributable the company to was $1.23 against loss of $0.59 for the same period of last year. Adjusted net income was $515 million against $454 million for the same period of last year. Adjusted diluted earnings per share was $1.52 against $1.37 for the same period of last year. Net cash provided by operating activities was $490 million against $110 million for the same period of last year. Capital expenditures were $52 million against $72 million for the same period of last year. Additions to computer software were $131 million against $95 million for the same period of last year. Free cash flow was $307 million against outflow of $57 million for the same period of last year. Unlevered free cash flow was $628 million against $576 million for the same period of last year. Net income included one-time IPO-related charges. As of December 31, 2015, cash and cash equivalents were $396 million and the principal amount of debt was $4,266 million, resulting in net debt of $3,870 million. The company expects constant currency results for full-year 2016 as follows: Revenue growth of 10% to 12%, Adjusted EBITDA growth of 7.5% to 9.5%, Adjusted Net Income growth of 6.5% to 8.5% and Adjusted Diluted Earnings per Share growth of 8.5% to 10.5%. Assuming foreign exchange rates hold at current levels through the end of 2016, The company expects reported revenue growth of 7.5% to 9.5%, Adjusted EBITDA growth of 6% to 8%, Adjusted Net Income growth of 0.5% to 2.5% and Adjusted Diluted Earnings per Share growth of 2.5% to 4.5%. The company extends its high teens cash tax rate guidance by two additional years. The company now expects its cash tax rate to remain in the high teens through mid-2023. For 2016, the company expects constant currency growth of 7.5% to 9.5%, suggesting sales between $3.14 billion to $3.20 billion. Adjusted diluted EPS is seen growing 2.5% to 4.5% or to between $1.56 and $1.59.

Valeant Canada Selects IMS Health’S Fully Integrated Customer Engagement Solution for Commercial Effectiveness

IMS Health announced a multi-year agreement with Valeant Canada to deploy IMS Health’s next-generation Orchestrated Customer Engagement (OCE) solution for advancing commercial effectiveness. The OCE solution for Valeant Canada integrates Nexxus Mobile IntelligenceCRM, Nexxus Marketing, cloud-based data warehousing and business intelligence analytics leveraging IMS Heath’s information and technology services to deliver intelligence and enhanced sales and marketing performance for improved customer interactions. IMS Health’s solution uniquely aligns mission-critical healthcare information and innovative SaaS applications for sales, marketing and market access empowering life sciences organizations to better coordinate customer engagement and achieve their commercial goals. Tightly synchronized with the IMS One cloud platform, OCE connects and streamlines complex processes in commercial management, from multi-channel marketing and social media monitoring to analytics for performance management. This end-to-end approach addresses the challenge of strengthening the relationship between life sciences companies and their customers, while increasing efficiency across all communication channels and boosting marketing ROI.

IMS Health Holdings, Inc. to Report Q4, 2015 Results on Feb 03, 2016

IMS Health Holdings, Inc. announced that they will report Q4, 2015 results at 9:00 AM, Eastern Standard Time on Feb 03, 2016

Similar Private Companies By Industry

Company Name Region
RAM Software Systems, Inc. United States
Carrum Health, Inc. United States
TeleMedTest, LLC United States
Caresquare.com, Inc. United States
Ellumen, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
February 4, 2016
Dimensions Healthcare, LLC
Merger/Acquisition
February 3, 2016
AlphaImpactRx, Inc.
Buyback
December 17, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact IMS Health Holdings, Inc., please visit www.imshealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.